Global Mental Disorders Drugs Market Size, Status and Forecast 2022
- QYR1051565
- 90 Pages
- March 2017
- Medical Devices
This report studies the global Mental Disorders Drugs market, analyzes and researches the Mental Disorders Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
...
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Mental Disorders Drugs can be split into
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others
Market segment by Application, Mental Disorders Drugs can be split into
Children
Adolescents
Adults
Global Mental Disorders Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Mental Disorders Drugs
1.1 Mental Disorders Drugs Market Overview
1.1.1 Mental Disorders Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Mental Disorders Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Mental Disorders Drugs Market by Type
1.3.1 Drugs for Schizophrenia
1.3.2 Antidepressants
1.3.3 Antipsychotics
1.3.4 Anxiolytics
1.3.5 Drugs for the Treatment of Substance and Alcohol Addiction
1.3.6 Drugs for Childhood and Adolescent Mental Illness
1.3.7 Drugs to Treat Cognitive Disorders
1.3.8 Sleep Disorders
1.3.9 Others
1.4 Mental Disorders Drugs Market by End Users/Application
1.4.1 Children
1.4.2 Adolescents
1.4.3 Adults
2 Global Mental Disorders Drugs Competition Analysis by Players
2.1 Mental Disorders Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Johnson and Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Pfizer
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Eli Lilly
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 AstraZeneca
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Mental Disorders Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
4 Global Mental Disorders Drugs Market Size by Type and Application (2012-2017)
4.1 Global Mental Disorders Drugs Market Size by Type (2012-2017)
4.2 Global Mental Disorders Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Mental Disorders Drugs in Future
4.4 Top Consumer/End Users of Mental Disorders Drugs
5 United States Mental Disorders Drugs Development Status and Outlook
5.1 United States Mental Disorders Drugs Market Size (2012-2017)
5.2 United States Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU Mental Disorders Drugs Development Status and Outlook
6.1 EU Mental Disorders Drugs Market Size (2012-2017)
6.2 EU Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan Mental Disorders Drugs Development Status and Outlook
7.1 Japan Mental Disorders Drugs Market Size (2012-2017)
7.2 Japan Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
8 China Mental Disorders Drugs Development Status and Outlook
8.1 China Mental Disorders Drugs Market Size (2012-2017)
8.2 China Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
9 India Mental Disorders Drugs Development Status and Outlook
9.1 India Mental Disorders Drugs Market Size (2012-2017)
9.2 India Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Mental Disorders Drugs Development Status and Outlook
10.1 Southeast Asia Mental Disorders Drugs Market Size (2012-2017)
10.2 Southeast Asia Mental Disorders Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Mental Disorders Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Mental Disorders Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Mental Disorders Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Mental Disorders Drugs Market Size by Application (2017-2022)
12 Mental Disorders Drugs Market Dynamics
12.1 Mental Disorders Drugs Market Opportunities
12.2 Mental Disorders Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Mental Disorders Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Mental Disorders Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Mental Disorders Drugs Product Scope
Figure Global Mental Disorders Drugs Market Size (Million USD) (2012-2017)
Table Global Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Mental Disorders Drugs Market Share by Regions in 2016
Figure United States Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Mental Disorders Drugs Market Share by Type in 2016
Figure Drugs for Schizophrenia Market Size (Million USD) and Growth Rate (2012-2017)
Figure Antidepressants Market Size (Million USD) and Growth Rate (2012-2017)
Figure Antipsychotics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Anxiolytics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Drugs for the Treatment of Substance and Alcohol Addiction Market Size (Million USD) and Growth Rate (2012-2017)
Figure Drugs for Childhood and Adolescent Mental Illness Market Size (Million USD) and Growth Rate (2012-2017)
Figure Drugs to Treat Cognitive Disorders Market Size (Million USD) and Growth Rate (2012-2017)
Figure Sleep Disorders Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Mental Disorders Drugs Market Share by Application in 2016
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Children (2012-2017)
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Adolescents (2012-2017)
Figure Mental Disorders Drugs Market Size (Million USD) and Growth Rate in Adults (2012-2017)
Table Mental Disorders Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Mental Disorders Drugs Market Size Share by Players in 2016
Figure Mental Disorders Drugs Market Size Share by Players in 2017
Table Johnson and Johnson Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Johnson and Johnson (2012-2017)
Figure Johnson and Johnson Mental Disorders Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Mental Disorders Drugs Business Revenue Market Share in 2016
Table Eli Lilly Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Eli Lilly (2012-2017)
Figure Eli Lilly Mental Disorders Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Mental Disorders Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Mental Disorders Drugs Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Mental Disorders Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Mental Disorders Drugs Business Revenue Market Share in 2016
Table Global Mental Disorders Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Mental Disorders Drugs Market Size Share by Type in 2012
Figure Global Mental Disorders Drugs Market Size Share by Type in 2013
Figure Global Mental Disorders Drugs Market Size Share by Type in 2014
Figure Global Mental Disorders Drugs Market Size Share by Type in 2015
Figure Global Mental Disorders Drugs Market Size Share by Type in 2016
Figure Global Mental Disorders Drugs Market Size Share by Type in 2017
Table Global Mental Disorders Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2012
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2013
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2014
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2015
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2016
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Mental Disorders Drugs
Figure United States Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Mental Disorders Drugs Market Size Share by Players in 2016
Figure United States Mental Disorders Drugs Market Size Share by Players in 2017
Figure EU Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Mental Disorders Drugs Market Size Share by Players in 2016
Figure EU Mental Disorders Drugs Market Size Share by Players in 2017
Figure Japan Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Mental Disorders Drugs Market Size Share by Players in 2016
Figure Japan Mental Disorders Drugs Market Size Share by Players in 2017
Figure China Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Mental Disorders Drugs Market Size Share by Players in 2016
Figure China Mental Disorders Drugs Market Size Share by Players in 2017
Figure India Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Mental Disorders Drugs Market Size Share by Players in 2016
Figure India Mental Disorders Drugs Market Size Share by Players in 2017
Figure Southeast Asia Mental Disorders Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Mental Disorders Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Mental Disorders Drugs Market Size Share by Players in 2016
Figure Southeast Asia Mental Disorders Drugs Market Size Share by Players in 2017
Figure Global Mental Disorders Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Mental Disorders Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Mental Disorders Drugs Market Size Share by Regions in 2017
Figure Global Mental Disorders Drugs Market Size Share by Regions in 2022
Figure United States Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Mental Disorders Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Mental Disorders Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Mental Disorders Drugs Market Size Share by Type in 2017
Figure Global Mental Disorders Drugs Market Size Share by Type in 2022
Table Global Mental Disorders Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2017
Figure Global Mental Disorders Drugs Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
